All news from Pathology & Microbiology

Risk To The Public In Congo "Very High" And The Regional Risk "High"

Reseachers examined that Congo's latest Ebola outbreak now has 14 confirmed cases as health officials rush to contain the often deadly virus in a city of more than 1 million. The World Health Organization was holding an experts' meeting on Friday to determine whether the epidemic warrants being declared a global health emergency. It now calls the risk to the public in Congo "very high" and the regional risk "high." The Republic of Congo and the Central African Republic are nearby.

Low Chance Of Health Care Can Be More At The End-Of-Life

Advances in medicine mean health care professionals can prolong life, yet some treatments have a low chance of providing tangible benefits to some patients, can result in a 'bad death' and represent a multi-million dollar cost to the public purse. The Australian-first Reducing Non-Beneficial Treatment at the End-of-Life collaboration between QUT health and law researchers has been awarded a $504,187.80 Partnership Grant from the National Health and Medical Research Council.

New Algorithm Predicts Accurately For Heart Failure Patients

According to a new study, researchers developed a new algorithm, which accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more personalized assessments of people who are awaiting heart transplants, which in turn could enable health care providers to make better use of limited life-saving resources and potentially reduce health care costs. The study was published in PLOS One.

New Treatment For Psoriasis Patients Using Antibody

An antibody used to treat the skin disease psoriasis and other chronic autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease has no effect on aortic inflammation a key marker of future risk of major cardiovascular events unlike other antibodies that target different aspects of the immune system. Researchers led a multi-center, randomized, double-blind, placebo-controlled study and found patients taking the drug adalimumab marketed as Humira saw no change in aortic inflammation, as assessed by nuclear imaging, when compared to the placebo group. 

Organ Transplantation Is A Last Treatment For Facing Any Diseases

According to the  U.S. Department of Health & Human Services, Organ transplantation is often a last treatment available to many patients facing end-stage diseases. More than 125,000 patients are currently on the wait list for an organ transplant, based on currently practiced approaches of accepting organs, the availability remains limited. Consequently, the health of these patients deteriorates and UNOS estimates that, on average, 20 people die each day while waiting for a transplant. The study was published in The New England Journal of Medicine.

Deprescribe BZRAs In Younger Adults As "Weak" For Adverse Effects

According to a new study, researchers evaluated a new clinical practice guideline focuses on helping clinicians to safely deprescribe benzodiazepine receptor agonists (BZRAs), including benzodiazepines, zopiclone, and zolpidem, in adult patients. The guideline's recommendations are based on data from key BZRA deprescribing trials for insomnia, as well as on the analysis of reviews of BZRA harms, patient preferences, and resource implications.

An Effective Treatment On Colon Cancer By Combination Therapies

Researchers have discovered that colon cancers are often resistant to existing drug treatments because they are composed of two different cell types that can replace each other when one cell type is killed. They suggests that combination therapies targeting both cell types at once may be more effective at treating colorectal cancer, the third highest cause of cancer-related death in the United States. The study was published in the Journal of Experimental Medicine.

New Insights Of Human Brain Affected From Schizophrenia

Researchers showed that organs, other than the brain, also change at the onset of the disease. Schizophrenia is considered a disorder of the mind, influencing the way a person thinks, feels and behaves. Scientists have known for a long time that people with schizophrenia have much higher rates of physical illness compared with the general population, and this contributes to startlingly high rates of premature death. People with the disorder die 15 to 20 years earlier than the average person.